🔗 Share this article

Treasury head Reeves has announced she is preparing "targeted steps to address cost of living pressures" in next month's Budget.

In comments to the BBC, she stated that lowering inflation is a collective responsibility of both the government and the Bank of England.

The UK's inflation rate is forecast to be the highest among the Group of Seven advanced economies this year and the following year.

Possible Energy Bill Interventions

Sources suggest the administration could intervene to reduce utility costs, for example by slashing the current 5% rate of VAT applied on energy supplies.

Another possibility is to reduce some of the government charges presently added to household expenses.

Fiscal Limitations and Analyst Expectations

The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for such measures.

The consensus from most analysts is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her self-imposed debt limits.

Earlier on Thursday, analysis indicated there was a twenty-two billion pound deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a shared job between the central bank and the government to continue tackling some of the sources of price increases," the Chancellor told the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Commitments and Global Concerns

While a great deal of the attention has been on probable tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with growing international and commercial tensions for the fiscal revenue measures, likely to be directed on those "wealthiest."

Global Economic Disputes

Addressing apprehensions about the United Kingdom's economic relations with China she said: "The UK's national security always are paramount."

Last week's statement by China to increase trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led US President Donald Trump to suggest an further 100% import tax on goods from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a international production power grab."

Inquired about accepting the US offer to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "harmful for the world economy and generates further challenges."

"In my view there are areas where we should address China, but there are also valuable prospects to trade with Chinese markets, including financial services and other areas of the economy. We've got to achieve that equilibrium correct."

The chancellor also affirmed she was working with international partners "regarding our own critical minerals plan, so that we are more independent."

NHS Drug Pricing and Funding

Reeves also admitted that the price the NHS pays for pharmaceuticals could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the world's largest drug companies have said recently that they are either pausing or canceling investments in the UK, with some attributing the insufficient payments they are getting.

Last month, the Science Minister said the price the health service spends on medicines would must go up to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "It has been observed as a result of the cost structure, that medical research, new drugs have not been offered in the UK in the manner that they are in other European countries."

"The objective is to guarantee that people getting treatment from the National Health Service are can access the finest essential drugs in the globe. And so we are examining all of that, and... seeking to secure increased investment into the UK."